Hydroxyurea 500mg – Globalstar International https://export.globalstarco.com Making Health Accessible. Thu, 05 Mar 2026 09:57:13 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 https://export.globalstarco.com/wp-content/uploads/2025/07/cropped-Site-Icon-32x32.png Hydroxyurea 500mg – Globalstar International https://export.globalstarco.com 32 32 Ibrutinib (140 mg) https://export.globalstarco.com/product/ibrutinib-140-mg/ https://export.globalstarco.com/product/ibrutinib-140-mg/#respond Wed, 18 Feb 2026 10:55:06 +0000 https://export.globalstarco.com/product/ibrutinib-140-mg/ Overview: Hydroxyurea Capsule 500 mg contains Hydroxyurea (500 mg) and is prescribed as an oral antineoplastic and antimetabolite medicine used in the treatment of chronic myeloid leukemia (CML), sickle cell anemia, and certain other cancers by inhibiting DNA synthesis in rapidly dividing cells. Key Benefits: – Helps control leukemic cell proliferation in CML – Reduces painful episodes in sickle cell anemia – Oral dosing for convenient administration Composition: Hydroxyurea (500 mg) How It Works: Hydroxyurea inhibits ribonucleotide reductase, an enzyme essential for DNA synthesis, slowing the replication of rapidly dividing cells including cancer cells and abnormal blood cells. Usage Instructions: – Take exactly as directed by your healthcare provider – Swallow the capsule with water, with or without food – Do not crush or chew the capsule Side Effects: – Low blood cell counts increasing infection and bleeding risk – Nausea, vomiting, diarrhea – Mouth sores, headache Precautions: – Regular monitoring of blood counts and organ function is required – Not recommended during pregnancy or breastfeeding unless clearly advised by a doctor – Inform your doctor of all current medications Storage Instructions: – Store below 30°C in a cool, dry place away from moisture and light Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

]]>
https://export.globalstarco.com/product/ibrutinib-140-mg/feed/ 0